SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Parenteral Drugs (India) submits confirmation certificate

29 Jan 2021 Evaluate

Parenteral Drugs (India) has informed that pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, the Company enclosed Confirmation Certificate for dematerialization requests, cancellation of certificates and consequential actions, if any, as received from Link Intime India, RTA of the Company for the third quarter of the financial year 2020-21 ended on 31st December, 2020.

The above information is a part of company’s filings submitted to BSE.

Parenteral Drugs Share Price

3.39 0.00 (0.00%)
21-Aug-2023 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×